What benefit might there be in very low nicotine combustible cigarettes? That is the essential question the US FDA must answer in assessing a modified risk tobacco product (MRTP) application from 22nd Century Group for its VLN products
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.